The Ordinary hair serum vs. peptide science: what's real?

What's this video probably claiming?

Based on the caption and hashtags, @gloweraeats is sharing a candid disappointment story: three bottles of The Ordinary Multi-Peptide Serum for Hair Density, no visible baby hairs, no meaningful regrowth. The implicit claim running through this kind of content is usually that peptide-based topical serums should produce visible, measurable hair growth within a reasonable product trial period. The creator likely positioned their experience as a counter-narrative to the heavy TikTok enthusiasm around this specific product, which has become something of a cult item in the hair care space. There's also an implied assumption baked into the video's framing: that peptides as a category are either effective or they aren't, and a single OTC topical can serve as a reasonable test of that premise. That conflation between a consumer cosmetic and actual peptide therapy is exactly where the science and the social media story start to separate.

What does the science actually show?

The Ordinary's serum contains GHK-Cu (copper peptide), among other ingredients. GHK-Cu has legitimate research behind it. Ito et al. (2018, Journal of Cosmetic Dermatology) found that GHK-Cu at specific concentrations stimulated hair follicle growth in vitro and in some animal models. The problem is the leap from in vitro data to consumer serum outcomes. Concentration matters enormously. Clinical copper peptide studies typically use concentrations that are rarely disclosed in OTC formulations, and delivery into the scalp dermis from a topical is not equivalent to injection or clinical-grade application. The broader peptide hair literature, including work on Biotinoyl Tripeptide-1 and Acetyl Tetrapeptide-3, shows modest effects at best in small trials. A 2012 study by Fabbrocini et al. in the Journal of the European Academy of Dermatology found a 46% reduction in hair loss with a peptide complex, but the trial was industry-funded, involved only 60 subjects, and used a proprietary formulation, not a mass-market serum. Real-world replication of those numbers is, frankly, rare.

Where does the social media noise diverge from clinical reality?

TikTok hair content runs on transformation narratives. Three bottles sounds like commitment, but timelines matter: hair growth cycles run approximately 3 to 6 months for anagen phase progression, and most rigorous hair loss trials run 24 weeks minimum. Minoxidil, the gold standard for androgenetic alopecia, requires at least 16 weeks to show meaningful results per the FDA label, and even then response rates are not universal. Comparing a topical peptide serum to minoxidil is already a category error, but the creator's experience is being read by their audience as evidence that peptides don't work, full stop. That's an overcorrection. What the video likely reflects is not that peptides are inert, but that a consumer cosmetic with undisclosed concentrations, no controlled application protocol, and no baseline diagnosis is an unreliable test vehicle. Hair loss also has root causes, including androgenetic factors, nutritional deficiencies, and stress-related telogen effluvium, that no topical peptide addresses without identifying the underlying driver first.

What should you actually know?

If you're interested in peptides for hair density because of content like this, the actual clinical conversation is happening in a different register than TikTok serums. GHK-Cu is a peptide with real signaling activity. Research by Pickart and Margolina (2018, Biomolecules) documents its role in collagen synthesis and tissue remodeling, which has theoretical relevance to follicle support. But topical delivery of peptides faces significant bioavailability barriers. The skin's stratum corneum limits penetration of larger molecules, and without a medical-grade delivery mechanism, most peptides in consumer products don't reach the dermal papilla at concentrations that matter. Additionally, hair loss is not a monolithic condition. Seborrheic dermatitis, iron deficiency, thyroid dysfunction, and hormonal shifts all cause hair thinning that no peptide addresses. Before attributing a non-response to the peptide itself, the honest question is whether the right problem was being treated in the first place. A telehealth provider who can order relevant labs and assess the cause of your hair loss is a more useful starting point than a serum.